BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38769124)

  • 1. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
    Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
    Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
    Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
    Han Q; Yan P; Song R; Liu F; Tian Q
    Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
    Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
    Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
    Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells.
    Jin X; Yang S; Lu X; Chen X; Dai W
    Breast Cancer Res; 2024 Jun; 26(1):92. PubMed ID: 38840145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H; Yin M; Qian W; Yin H
    Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
    Song M; Wang Y; Zhang Z; Wang S
    Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
    Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
    Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
    Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J; Liu C; Shi J; Wen K; Wang X
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
    Ma K; Zhang C; Li W
    Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
    Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
    Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.